A study to determine the safety and anti-viral activity of ARB-1740 in patients with chronic hepatitis B virus (HBV) infection.
Phase 1
- Conditions
- Chronic hepatitis B virus infection
- Registration Number
- ACTRN12617000557336
- Lead Sponsor
- Arbutus Biopharma Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method